PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 1, 1993Journal of the American Society of Nephrology67 citationsOpen Access

Endothelium-derived relaxing factor, nitric oxide

LRLeopoldo RaijPSP J Shultz

Structured PICO

P
Population
Glomerular mesangial cells in vitro and in vivo
I
Intervention
Endothelium-derived relaxing factor, nitric oxide (EDRF/NO)
O
Outcome
Effects on cGMP, mesangial cell contraction, and proliferationsurrogate

EDRF/NO plays a significant role in glomerular mesangial cell physiology and pathophysiology, particularly during inflammation and endotoxemia.

Abstract

The endothelium-derived relaxing factor nitric oxide (EDRF/NO) is a labile, endogenous vasodilator that is important in the control of systemic vascular tone. This review focuses on the effects of EDRF/NO on glomerular mesangial cells in vitro and on the role of EDRF/NO in mesangial and glomerular physiology and pathophysiology in vivo. It was concluded that EDRF/NO can stimulate increases in cGMP, inhibit mesangial cell contraction, and inhibit growth factor-induced proliferation of mesangial cells in culture. Furthermore, incubation with endotoxin or cytokines stimulates mesangial cells to produce EDRF/NO, via an inducible NO synthase enzyme. Therefore, it is likely that NO could play a role in the inflammatory response within the glomerulus. Finally, recent studies providing evidence that EDRF/NO is functional within the glomerulus in vivo, especially during endotoxemia and inflammation are also reviewed.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Raij et al. (1993) studied this question.

synapsesocial.com/papers/6a71b7c48031ec7bb1dd166dhttps://doi.org/10.1681/asn.v381435
Ask AI
Helpful
Bookmark
Share
View Full Paper